Literature DB >> 23812093

Identification of cut-points in commonly used hip osteoarthritis-related outcome measures that define the patient acceptable symptom state (PASS).

Alicia J Emerson Kavchak1, Chad Cook, Eric J Hegedus, Alexis A Wright.   

Abstract

To determine patient acceptable symptom state (PASS) estimates in outcome measures commonly used in hip osteoarthritis (OA). Identification of cut-points on commonly used outcome measures associated with patient satisfaction with their current state of health. As part of a randomized controlled trial, 70 patients with a clinical diagnosis of hip OA undergoing a 9-session physiotherapy treatment program completed four physical performance measures and three self-report measures at 9 weeks and 1 year. Upon completion of treatment, patients assessed their current health status according to the PASS question. Cut-points were estimated using receiver operating characteristic curves (anchor-based method), based on the patient's response to the PASS question. At 9 weeks and 1 year, identified cut-points were, respectively, ≤10 and ≤11 for the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale; ≤35 and ≤40 on the WOMAC physical function subscale; ≥+5 and ≥+6 on the global rating of change score; ≤6.05 and ≤5.30 s for the timed-up-and-go; ≤28.3 and ≤24.9 for the 40-m self-paced walk test; ≥11 and ≥12 repetitions for the 30-s chair stand test; and ≥46 repetitions for the 20-cm step test. Initial target cut-points signaling patient satisfaction with their current symptom state following physiotherapy in patients with hip osteoarthritis were determined for seven outcome measures over 1 year.

Entities:  

Mesh:

Year:  2013        PMID: 23812093     DOI: 10.1007/s00296-013-2813-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  46 in total

Review 1.  Understanding the minimum clinically important difference: a review of concepts and methods.

Authors:  Anne G Copay; Brian R Subach; Steven D Glassman; David W Polly; Thomas C Schuler
Journal:  Spine J       Date:  2007-04-02       Impact factor: 4.166

2.  The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition.

Authors:  S Gupta; G A Hawker; A Laporte; R Croxford; P C Coyte
Journal:  Rheumatology (Oxford)       Date:  2005-08-09       Impact factor: 7.580

3.  Responsiveness of the numeric pain rating scale in patients with low back pain.

Authors:  John D Childs; Sara R Piva; Julie M Fritz
Journal:  Spine (Phila Pa 1976)       Date:  2005-06-01       Impact factor: 3.468

Review 4.  Normal walking speed: a descriptive meta-analysis.

Authors:  Richard W Bohannon; A Williams Andrews
Journal:  Physiotherapy       Date:  2011-05-11       Impact factor: 3.358

5.  Baseline dependency of minimal clinically important improvement.

Authors:  Ying-Chih Wang; Dennis L Hart; Paul W Stratford; Jerome E Mioduski
Journal:  Phys Ther       Date:  2011-03-03

6.  Relationship between self-reported and performance-based tests in a hip and knee joint replacement population.

Authors:  Rajiv Gandhi; Dmitry Tsvetkov; J Roderick Davey; Khalid A Syed; Nizar N Mahomed
Journal:  Clin Rheumatol       Date:  2008-10-08       Impact factor: 2.980

7.  Understanding the pain experience in hip and knee osteoarthritis--an OARSI/OMERACT initiative.

Authors:  G A Hawker; L Stewart; M R French; J Cibere; J M Jordan; L March; M Suarez-Almazor; R Gooberman-Hill
Journal:  Osteoarthritis Cartilage       Date:  2008-03-04       Impact factor: 6.576

8.  Scientific and clinical problems in indexes of functional disability.

Authors:  A R Feinstein; B R Josephy; C K Wells
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

9.  Reliability of performance-based measures in people awaiting joint replacement surgery of the hip or knee.

Authors:  Stephen Gill; Helen McBurney
Journal:  Physiother Res Int       Date:  2008-09

10.  Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis.

Authors:  Maxime Dougados; Alan Moore; Shaohua Yu; Xavier Gitton
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  4 in total

1.  Survivorship of the Bernese Periacetabular Osteotomy: What Factors are Associated with Long-term Failure?

Authors:  Joel Wells; Michael Millis; Young-Jo Kim; Evgeny Bulat; Patricia Miller; Travis Matheney
Journal:  Clin Orthop Relat Res       Date:  2016-05-12       Impact factor: 4.176

2.  The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life.

Authors:  Paswach Wiriyakijja; Stephen Porter; Stefano Fedele; Tim Hodgson; Roddy McMillan; Martina Shephard; Richeal Ni Riordain
Journal:  Clin Oral Investig       Date:  2020-11-17       Impact factor: 3.573

3.  What Mid-term Patient-reported Outcome Measure Scores, Reoperations, and Complications Are Associated with Concurrent Hip Arthroscopy and Periacetabular Osteotomy to Treat Dysplasia with Associated Intraarticular Abnormalities?

Authors:  Adam I Edelstein; Jeffrey J Nepple; Wahid Abu-Amer; Cecilia Pascual-Garrido; Charles W Goss; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

4.  Construct validity of the OCTOPuS stratification algorithm for allocating patients with knee osteoarthritis into subgroups.

Authors:  Jesper Knoop; Raymond W J G Ostelo; Martin van der Esch; Arjan de Zwart; Kim L Bennell; Marike van der Leeden; Joost Dekker
Journal:  BMC Musculoskelet Disord       Date:  2021-07-21       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.